Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pei-Jen Kang
Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Related publications
Hepatocellular Carcinoma: High Hepatitis B Viral Load and Mortality in Patients Treated With Transarterial Chemoembolization
Radiology
Nuclear Medicine
Radiology
Imaging
Letter: Risk of Developing Hepatocellular Carcinoma in Untreated HBeAg-negative Chronic Hepatitis B Patients With High Viral Load and No Significant ALT Elevation
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
249ser TP53 Mutation in Plasma DNA, Hepatitis B Viral Infection, and Risk of Hepatocellular Carcinoma
Oncogene
Cancer Research
Genetics
Molecular Biology
Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Risk of Developing Hepatocellular Carcinoma in Untreated HBeAg-negative Chronic Hepatitis B Patients With High Viral Load and No Significant ALT Elevation. Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma-Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Clinical Utility of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B
Liver International
Hepatology
